- Home
- ARTL vs VSA Comparison
ARTL vs VSA Comparison
Compare ARTL & VSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTL
- VSA
- Stock Information
- Founded
- ARTL 2011
- VSA 2002
- Country
- ARTL United States
- VSA China
- Employees
- ARTL N/A
- VSA N/A
- Industry
- ARTL Biotechnology: Pharmaceutical Preparations
- VSA
- Sector
- ARTL Health Care
- VSA
- Exchange
- ARTL Nasdaq
- VSA NYSE
- Market Cap
- ARTL 3.6M
- VSA 4.2M
- IPO Year
- ARTL N/A
- VSA N/A
- Fundamental
- Price
- ARTL $0.95
- VSA $0.48
- Analyst Decision
- ARTL Strong Buy
- VSA
- Analyst Count
- ARTL 2
- VSA 0
- Target Price
- ARTL $5.50
- VSA N/A
- AVG Volume (30 Days)
- ARTL 1.2M
- VSA 1.2M
- Earning Date
- ARTL 05-12-2025
- VSA 01-01-0001
- Dividend Yield
- ARTL N/A
- VSA N/A
- EPS Growth
- ARTL N/A
- VSA N/A
- EPS
- ARTL N/A
- VSA N/A
- Revenue
- ARTL N/A
- VSA $190,004,403.00
- Revenue This Year
- ARTL N/A
- VSA $99.90
- Revenue Next Year
- ARTL N/A
- VSA N/A
- P/E Ratio
- ARTL N/A
- VSA N/A
- Revenue Growth
- ARTL N/A
- VSA N/A
- 52 Week Low
- ARTL $0.82
- VSA $0.27
- 52 Week High
- ARTL $1.59
- VSA $0.49
- Technical
- Relative Strength Index (RSI)
- ARTL 50.27
- VSA N/A
- Support Level
- ARTL $0.82
- VSA N/A
- Resistance Level
- ARTL $1.40
- VSA N/A
- Average True Range (ATR)
- ARTL 0.11
- VSA 0.00
- MACD
- ARTL 0.02
- VSA 0.00
- Stochastic Oscillator
- ARTL 23.10
- VSA 0.00
About ARTL Artelo Biosciences Inc.
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network in body. It is focused on discovering, licensing, developing, and commercializing treatments that control endocannabinoid systems. The company pursues technologies and programs that offer proprietary approaches to cannabinoid-based therapies, also those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.
About VSA TCTM KIDS IT EDUCATION INC SPON ADS EA REP 5 ORD SHS(POST REV SPLT)
TCTM Kids IT Education Inc engages in the provision of IT-focused education services in Mainland China. The company has a single reportable segment: IT-focused Supplementary STEM Education Services. It offers supplementary science, technology, engineering, and mathematics (STEM) education programs to young children aged between three and eighteen through online teaching models and instructors from online or offline learning centers. The company also operates an education platform that offers distance instruction, classroom-based learning, and online learning modules.